Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
通过肿瘤内电穿孔导入CXCL9质粒扩增CXCR3/CXCL9轴，可与IL-12质粒疗法协同作用，诱导强大的抗肿瘤免疫反应。
期刊:Molecular Therapy-Oncolytics
影响因子:5.3
doi:10.1016/j.omto.2022.04.005
Lee, Jack Y; Nguyen, Bianca; Mukhopadhyay, Anandaroop; Han, Mia; Zhang, Jun; Gujar, Ravindra; Salazar, Jon; Hermiz, Reneta; Svenson, Lauren; Browning, Erica; Lyerly, H Kim; Canton, David A; Fisher, Daniel; Daud, Adil; Algazi, Alain; Skitzki, Joseph; Twitty, Christopher G
